World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
35709
World Ranking
11196
National Ranking
150

Walter Weder publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Walter Weder sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 737 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Walter Weder D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Walter Weder sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Walter Weder is affiliated with the University of Zurich in Switzerland and focuses primarily on research within the field of medicine. Their work spans several subfields including pulmonary and respiratory medicine, oncology, surgery, radiology, nuclear medicine and imaging, as well as neurology. This multidisciplinary approach informs their studies on lung cancer, pleural and pulmonary diseases, and related respiratory conditions.

The scientist's main topics of investigation include:

  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Pleural and Pulmonary Diseases
  • Lung Cancer Research Studies
  • Occupational and Environmental Lung Diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Tracheal and Airway Disorders

Recent significant publications authored or co-authored by Walter Weder include:

  • IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy, 2020, Journal of Thoracic Oncology
  • Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer, 2021, Nature Reviews Clinical Oncology
  • SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial, 2021, Journal of Clinical Oncology
  • ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma, 2020, European Respiratory Journal
  • Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for EGFR-Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA, 2021, Future Oncology

Their frequent collaborators include:

  • Isabelle Opitz
  • İlhan İnci
  • Jamie E. Chaft
  • Laurens J. Ceulemans
  • Thomas Frauenfelder

Walter Weder's work has appeared extensively in specialized publication venues related to cardio-thoracic surgery and oncology:

  • European Journal of Cardio-Thoracic Surgery
  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Lung Cancer
  • European Respiratory Journal

Their research contributes to understanding and advancing treatment options for lung cancer and other respiratory diseases, integrating clinical and surgical perspectives with oncology and imaging techniques. The volume of publications and recurring topics reflect a focus on both systemic therapies and surgical interventions for thoracic diseases.

Best Publications

  • Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

    Didier Lardinois;Walter Weder;Thomas F Hany;Ehab M Kamel

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

  • Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.

    Paul De Leyn;Christophe Dooms;Jaroslaw Kuzdzal;Didier Lardinois

  • ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer

    Didier Lardinois;Paul De Leyn;Paul Van Schil;Ramon Rami Porta

  • Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

    A Scherpereel;P Astoul;P Baas;T Berghmans

  • A genomics-based classification of human lung tumors

    Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer

  • ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer

    Paul De Leyn;Didier Lardinois;Paul E. Van Schil;Ramon Rami-Porta

  • Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

    Daniel C. Betticher;Shu Fang Hsu Schmitz;Martin Tötsch;Eva Hansen

  • Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    L. Crinò;W. Weder;J. van Meerbeeck;E. Felip

  • 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    J. Vansteenkiste;L. Crinò;C. Dooms;J. Y. Douillard

  • Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.

    H C Steinert;M Hauser;F Allemann;H Engel

  • 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    W.E.E. Eberhardt;D. De Ruysscher;W. Weder;C. Le Péchoux

  • Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P. Baas;D. Fennell;K. M. Kerr;P. E. Van Schil

  • Initial analysis of the international association for the study of lung cancer mesothelioma database.

    Valerie W. Rusch;Dorothy Giroux;Catherine Kennedy;Enrico Ruffini

  • Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma

    W Weder;R A Stahel;J Bernhard;S Bodis

  • Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

    Miklos Pless;Roger Stupp;Roger Stupp;Hans Beat Ris;Rolf A. Stahel

  • Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

    Keith M. Kerr;Lukas Bubendorf;Martin J. Edelman;Antonio Marchetti

  • Anesthetic-induced improvement of the inflammatory response to one-lung ventilation.

    Elisena De Conno;Marc P. Steurer;Moritz Wittlinger;Marco P. Zalunardo

  • Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

    Oliver Gautschi;Colette Bigosch;Barbara Huegli;Monika Jermann

  • EML4-ALK Fusion Lung Cancer: A Rare Acquired Event

    Sven Perner;Patrick L Wagner;Francesca Demichelis;Rohit Mehra

Frequent Co-Authors

Rolf A. Stahel
Rolf A. Stahel University of Zurich
Solange Peters
Solange Peters University Hospital of Lausanne
Holger Moch
Holger Moch University of Zurich
Burkhardt Seifert
Burkhardt Seifert University of Zurich
Lukas Bubendorf
Lukas Bubendorf University Hospital of Basel
Roger Stupp
Roger Stupp Northwestern University
Keith M. Kerr
Keith M. Kerr Aberdeen Royal Infirmary
Paul Baas
Paul Baas Antoni van Leeuwenhoek Hospital
Walter Klepetko
Walter Klepetko Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are various alternative routes into healthcare for those interested in the medical field but seeking flexibility or different career paths. Many students explore nursing, public health, and allied health degrees, which offer rewarding opportunities and may have a quicker entry into the healthcare workforce.

Some learners begin their careers by enrolling in adn programs (Associate Degree in Nursing), known for easier entry requirements and shorter completion times. Others opt for the cheapest rn to bsn program online to upgrade their credentials as registered nurses affordably while balancing work and study.

For non-nurses with a bachelor’s degree in another field, accelerated online direct entry msn programs for non-nursing majors provide a fast path into advanced nursing practice. Experienced nurses interested in research or leadership roles might consider an online phd nursing for the highest level of academic achievement.

Exploring these diverse pathways expands your possibilities within healthcare, offering flexibility, affordability, and a range of specialties to suit different interests and backgrounds.

Best Scientists Citing Walter Weder

Trending Scientists

Recently Published Articles